Skip to product information
1 of 1

OX40/TNFRSF4/CD134 Fc Chimera Protein, Mouse

OX40/TNFRSF4/CD134 Fc Chimera Protein, Mouse

Catalog Number: UA010828 Reactivity: Mouse Conjugation: Unconjugated Brand: UA BIOSCIENCE
Price:
Regular price $276 USD
Regular price Sale price $276 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Mouse
Synonyms Txgp1; OX40L receptor; ACT35
Accession P47741
Amino Acid Sequence

Val20-Pro211 with Human IgG1 Fc at C-Terminus

Expression System HEK293
Molecular Weight 60-72kDa (Reducing)
Purity >95% by SDS-PAGE
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag Human IgG1 Fc
Physical Appearance Lyophilized Powder
Storage Buffer PBS, PH7.4
Reconstitution Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
Stability & Storage

· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. 
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.  
· Please avoid repeated freeze-thaw cycles.

Reference

1. Cancer Res. Roles of OX40 in the pathogenesis and the control of diseases.Int J Hematol . 2006 Jan;83(1):17-22. Toshiyuki Hori.

Background

OX40 is a member of the tumor necrosis factor receptor superfamily, and its expression is primarily restricted to activated T-cells. The ligation of OX40 during the interaction between T-cells and dendritic cells is crucial for the clonal expansion of antigen-specific T-cells and the generation of T-cell memory. Recent studies using animal models have highlighted the critical role of OX40 in the pathogenesis of various immunologic abnormalities, including inflammatory, autoimmune, infectious, allergic, and allotransplantation-related diseases. Blocking the OX40-OX40L interaction (where OX40L is the ligand of OX40) has been shown to prevent, cure, or ameliorate these diseases. Conversely, OX40 activation is known to disrupt tolerance in malignancies, leading to a reactivation of antitumor immunity. These findings strongly suggest that the OX40/OX40L system is one of the most promising targets for immune intervention in the treatment of these diseases.

Picture

SDS-PAGE

1μg (R: reducing condition).

ELISA

Immobilized OX40 Ligand/TNFSF4 His Tag Protein, Mouse (Cat. No. UA011097) at 2.0μg/mL (100μL/well) can bind OX40/TNFRSF4/CD134 Fc Chimera Protein, Mouse (Cat. No. UA010828) with EC50 of 7.49-15.49 ng/mL.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)